Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Aspirin improves MS-related fatigue

June 24, 1998

Lilly presents results of first clinical trial evaluating the MDR modulator LY-335979

June 23, 1998

Czech investigators describe novel CDK inhibitor with potent antitumor activity

June 23, 1998

SB-RA-131012, an MDR-reversing taxane

June 23, 1998

ZD-1839, an EGFR-TK inhibitor worthy of further testing

June 23, 1998

Aphton and SmithKline Beecham form alliance for Gonadimmune

June 22, 1998

SB-T-101131, a second-generation taxane with improved efficacy in MDR tumors

June 22, 1998

L-NDDP, a liposomal cisplatin derivative in phase II testing

June 22, 1998

Combretastatin potentiates antitumor efficacy of chemo- and radiotherapy in preclinical studies

June 22, 1998

BBR-3438, a promising new agent for prostate cancer

June 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...